» Articles » PMID: 39825080

Evolution of the Umbilical Cord Blood Proteome Across Gestational Development

Abstract

Neonatal health is dependent on early risk stratification, diagnosis, and timely management of potentially devastating conditions, particularly in the setting of prematurity. Many of these conditions are poorly predicted in real-time by clinical data and current diagnostics. Umbilical cord blood may represent a novel source of molecular signatures that provides a window into the state of the fetus at birth. In this study, we comprehensively characterized the cord blood proteome of infants born between 25 to 42 weeks using untargeted mass spectrometry and functional enrichment analysis. We determined that the cord blood proteome at birth varies significantly across gestational development. Proteins that function in structural development and growth (e.g., extracellular matrix organization, lipid particle remodeling, and blood vessel development) are more abundant earlier in gestation. In later gestations, proteins with increased abundance are in immune response and inflammatory pathways, including complements and calcium-binding proteins. These data contribute to the knowledge of the physiologic state of neonates across gestational age, which is crucial to understand as we strive to best support postnatal development in preterm infants, determine mechanisms of pathology causing adverse health outcomes, and develop cord blood biomarkers to help tailor our diagnosis and therapeutics for critical neonatal conditions.

References
1.
Anderson J, Minh Thang C, Thanh L, Thi Trang Dai V, Phan V, Thi Hong Nhu B . Immune Profiling of Cord Blood From Preterm and Term Infants Reveals Distinct Differences in Pro-Inflammatory Responses. Front Immunol. 2021; 12:777927. PMC: 8591285. DOI: 10.3389/fimmu.2021.777927. View

1.
Wong C, Buckner C, Lage S, Pei L, Assis F, Dahlstrom E . Rapid Emergence of T Follicular Helper and Germinal Center B Cells Following Antiretroviral Therapy in Advanced HIV Disease. Front Immunol. 2021; 12:752782. PMC: 8686113. DOI: 10.3389/fimmu.2021.752782. View

2.
Suski M, Bokiniec R, Szwarc-Duma M, Madej J, Bujak-Gizycka B, Borszewska-Kornacka M . Plasma proteome changes in cord blood samples from preterm infants. J Perinatol. 2018; 38(9):1182-1189. DOI: 10.1038/s41372-018-0150-7. View

3.
Geyer P, Holdt L, Teupser D, Mann M . Revisiting biomarker discovery by plasma proteomics. Mol Syst Biol. 2017; 13(9):942. PMC: 5615924. DOI: 10.15252/msb.20156297. View

4.
Hansmeier N, Chao T, Goldman L, Witter F, Halden R . Prioritization of biomarker targets in human umbilical cord blood: identification of proteins in infant blood serving as validated biomarkers in adults. Environ Health Perspect. 2012; 120(5):764-9. PMC: 3346780. DOI: 10.1289/ehp.1104190. View